ID18095A - Turunan tetrahidrokinolin - Google Patents

Turunan tetrahidrokinolin

Info

Publication number
ID18095A
ID18095A IDP972834A ID972834A ID18095A ID 18095 A ID18095 A ID 18095A ID P972834 A IDP972834 A ID P972834A ID 972834 A ID972834 A ID 972834A ID 18095 A ID18095 A ID 18095A
Authority
ID
Indonesia
Prior art keywords
tetrahidrokinolin
tetrahidrokinolin down
Prior art date
Application number
IDP972834A
Other languages
English (en)
Indonesian (id)
Inventor
Romano Di-Fabio
Alessandra Pasquarello
Fabio Maria Sabbatini
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of ID18095A publication Critical patent/ID18095A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDP972834A 1996-08-17 1997-08-14 Turunan tetrahidrokinolin ID18095A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9617305.9A GB9617305D0 (en) 1996-08-17 1996-08-17 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
ID18095A true ID18095A (id) 1998-02-26

Family

ID=10798623

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972834A ID18095A (id) 1996-08-17 1997-08-14 Turunan tetrahidrokinolin

Country Status (34)

Country Link
US (1) US6479488B1 (pl)
EP (1) EP0922034B1 (pl)
JP (1) JP4108129B2 (pl)
KR (1) KR100552864B1 (pl)
CN (1) CN1131214C (pl)
AP (1) AP877A (pl)
AR (1) AR008296A1 (pl)
AT (1) ATE221052T1 (pl)
AU (1) AU724473B2 (pl)
BR (1) BR9711311B1 (pl)
CA (1) CA2264118C (pl)
CO (1) CO4900066A1 (pl)
CZ (1) CZ296250B6 (pl)
DE (1) DE69714265T2 (pl)
DK (1) DK0922034T3 (pl)
EA (1) EA001704B1 (pl)
ES (1) ES2181030T3 (pl)
GB (1) GB9617305D0 (pl)
HU (1) HU225797B1 (pl)
ID (1) ID18095A (pl)
IL (1) IL128141A0 (pl)
IS (1) IS4953A (pl)
MY (1) MY116952A (pl)
NO (1) NO312241B1 (pl)
NZ (1) NZ333812A (pl)
PE (1) PE107098A1 (pl)
PL (1) PL194532B1 (pl)
PT (1) PT922034E (pl)
SI (1) SI0922034T1 (pl)
TR (1) TR199900336T2 (pl)
TW (1) TW449582B (pl)
WO (1) WO1998007704A1 (pl)
YU (1) YU6799A (pl)
ZA (1) ZA977326B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706294D0 (en) * 1997-03-26 1997-05-14 Glaxo Wellcome Spa Heterocyclic compound
MY125037A (en) 1998-06-10 2006-07-31 Glaxo Wellcome Spa 1,2,3,4 tetrahydroquinoline derivatives
US6455734B1 (en) 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
GB9929037D0 (en) * 1999-12-08 2000-02-02 Glaxo Wellcome Spa Heterocyclic derivatives
DE10132725A1 (de) 2001-07-05 2006-08-03 Grünenthal GmbH Substituierte γ-Lactonverbindungen
NZ533566A (en) * 2001-12-28 2007-03-30 Acadia Pharm Inc Tetrahydroquinoline analogues as muscarinic agonists
AU2004206931A1 (en) * 2003-01-23 2004-08-05 Acadia Pharmaceuticals Inc. Use of N-desmethylclozapine to treat human neuropsychiatric disease
US20050085463A1 (en) * 2003-01-23 2005-04-21 Weiner David M. Use of N-desmethylclozapine to treat human neuropsychiatric disease
US20050250767A1 (en) * 2003-01-23 2005-11-10 Weiner David M Use of N-desmethylclozapine to treat human neuropsychiatric disease
EP1596867A4 (en) * 2003-02-19 2006-03-22 Merck & Co Inc TREATMENT OF PSYCHOSIS WITH A MUSCARIN M1 RECEPTOR ECTOPIC ACTIVATOR
CA2550735A1 (en) * 2003-12-22 2005-07-14 Acadia Pharmaceuticals Inc. Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
CN1950346A (zh) * 2004-04-01 2007-04-18 阿卡蒂亚药品公司 N－去甲基氯氮平的晶形
RU2451014C2 (ru) * 2005-07-22 2012-05-20 Мотида Фармасьютикал Ко., Лтд. Новое производное гетероциклиден ацетамида
JP4754566B2 (ja) 2005-07-22 2011-08-24 持田製薬株式会社 新規なヘテロシクリデンアセトアミド誘導体
JP5399072B2 (ja) 2005-09-12 2014-01-29 アベラ ファーマスーティカルズ インコーポレイテッド ジメチルスルホキシド（ｄｍｓｏ）若しくは関連化合物、又はそれに関連する臭気を除去するシステム
EP2324838A1 (en) * 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Compositions Comprising Dimethyl Sulfoxide (DMSO)
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
WO2007053618A1 (en) * 2005-10-31 2007-05-10 Acadia Pharmaceuticals Inc. Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
AU2010313253B2 (en) 2009-10-30 2015-02-19 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
AU2012321345B2 (en) 2011-10-03 2016-03-17 The University Of Utah Research Foundation Application of 5-HT6 receptor antagonists for the alleviation of cognitive deficits of down syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE147732T1 (de) * 1989-03-08 1997-02-15 Merck Sharp & Dohme Tetrahydroquinolin-derivate, verwendbar bei neurodegenerativen krankheiten
ATE221520T1 (de) * 1995-09-29 2002-08-15 Glaxo Wellcome Spa Tetrahydrochinoline als nmda antagonisten

Also Published As

Publication number Publication date
KR20000068172A (ko) 2000-11-25
HU225797B1 (en) 2007-09-28
KR100552864B1 (ko) 2006-02-20
NO990723L (no) 1999-04-14
PL194532B1 (pl) 2007-06-29
EP0922034A1 (en) 1999-06-16
AP877A (en) 2000-09-27
DK0922034T3 (da) 2002-11-18
BR9711311B1 (pt) 2009-01-13
JP4108129B2 (ja) 2008-06-25
HUP9903108A3 (en) 2004-04-28
NZ333812A (en) 2000-07-28
IL128141A0 (en) 1999-11-30
DE69714265T2 (de) 2003-03-06
WO1998007704A1 (en) 1998-02-26
SI0922034T1 (en) 2003-02-28
IS4953A (is) 1999-01-22
AU4551897A (en) 1998-03-06
AP9901459A0 (en) 1999-03-31
ZA977326B (en) 1999-02-15
PE107098A1 (es) 1999-01-15
CO4900066A1 (es) 2000-03-27
AU724473B2 (en) 2000-09-21
US6479488B1 (en) 2002-11-12
YU6799A (sh) 2000-03-21
EA001704B1 (ru) 2001-06-25
TR199900336T2 (xx) 1999-04-21
CN1227544A (zh) 1999-09-01
CA2264118A1 (en) 1998-02-26
TW449582B (en) 2001-08-11
CN1131214C (zh) 2003-12-17
EP0922034B1 (en) 2002-07-24
AR008296A1 (es) 1999-12-29
NO990723D0 (no) 1999-02-16
DE69714265D1 (de) 2002-08-29
CA2264118C (en) 2008-06-17
CZ296250B6 (cs) 2006-02-15
MY116952A (en) 2004-04-30
PT922034E (pt) 2002-12-31
NO312241B1 (no) 2002-04-15
BR9711311A (pt) 1999-08-17
JP2001508031A (ja) 2001-06-19
ATE221052T1 (de) 2002-08-15
EA199900121A1 (ru) 1999-10-28
GB9617305D0 (en) 1996-09-25
CZ52999A3 (cs) 1999-07-14
PL331562A1 (en) 1999-07-19
ES2181030T3 (es) 2003-02-16

Similar Documents

Publication Publication Date Title
DE69728138D1 (de) 6-phenylpyridinderivate
NO973661D0 (no) Fjerndoseringsanalyttkonsentrasjonsmåler
PT920431E (pt) Tienopirimidinas
ID17781A (id) Turunan-turunan laktam
ID19474A (id) Turunan tiazola
NO984559L (no) TrÕlskovl
EP0904148A4 (en) Turbo aerator
NO990207L (no) Lokkfat
DE59709159D1 (de) Dihydrofuran-carboxamide
ID17666A (id) Pirazol parasitisida
DE69736653D1 (de) Farbbildabtastgerät
FI962767A0 (fi) Dataoeverfoeringsfoerfarande
NO970180D0 (no) Spylebörste
FI962245A0 (fi) Planteringslaoda
NO993129D0 (no) SymbollÕsedetektor
ID18323A (id) Turunan-turunan 1-karba-(detia)-sefalosporin
DE69711532D1 (de) Lithiumborosilikatphosphor
DE69733874D1 (de) Opalglaszusammensetzungen
FI2614U1 (fi) Parvekelasitusrakenne
IT240151Y1 (it) Appendipadelle
NO964769D0 (no) Ventilasjonsklosett
ITVR960018V0 (it) Porta-schedario
FI964760A0 (fi) Staellning
FI960237A0 (fi) Injektions- och taetningsmassa
FI964337A0 (fi) Glidyta foer slalombacke